BioMed Central Infectious Diseases
Cervical cancer is the most common female cancer in Rwanda that, in 2011, became the first African country to implement a national vaccination programme against human papillomavirus (HPV). To provide a robust baseline for future evaluations of vaccine effectiveness, cervical cell specimens were obtained from 2508 women aged 18–69 years from the general population in Kigali, Rwanda, during 2013/14. 20 % of women were HIV-positive. Samples were used for liquid-based cytology and HPV testing (44 types) with GP5+/6+ PC.
Dartmouth Digital Commons Citation
Ngabo, Fidele; Franceschi, Silvia; Baussano, Iacopo; Umulisa, M. Chantal; Snijders, Peter; Uyterlinde, Anne; Lazzarato, Fulvio; Tenet, Vanessa; Gatera, Maurice; Binagwaho, Agnes; and Clifford, Gary, "Human Papillomavirus Infection in Rwanda at the Moment of Implementation of a National HPV Vaccination Programme" (2016). Dartmouth Scholarship. 626.